Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Niclosamide intramuscular depot - Daewoong Pharmaceutical/ Institut Pasteur Korea

Next Previous
X
Search
Drug Profile

Niclosamide intramuscular depot - Daewoong Pharmaceutical/ Institut Pasteur Korea

Alternative Names: DWRX 2003; Niclosamide - Daewoong Pharmaceutical/ Institut Pasteur Korea; Niclosamide IM Depot - Daewoong Pharmaceutical/ Institut Pasteur Korea

Latest Information Update: 28 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Daewoong Pharmaceutical; Institut Pasteur Korea
  • Developer Daewoong Pharmaceutical
  • Class Anthelmintics; Anti-inflammatories; Antibacterials; Antineoplastics; Antivirals; Benzamides; Chlorophenols; Nitrobenzenes; Skin disorder therapies; Small molecules
  • Mechanism of Action Autophagy stimulants; Mitochondrial oxidative phosphorylation uncouplers; MTOR protein inhibitors; Notch signalling pathway inhibitors; STAT3 transcription factor inhibitors; Virus internalisation inhibitors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II COVID 2019 infections
  • No development reported Influenza virus infections; Lung disorders

Most Recent Events

  • 28 Oct 2024 No recent reports of development identified for preclinical development in Influenza-virus-infections in South Korea (IM, Controlled release)
  • 28 Jan 2024 No recent reports of development identified for preclinical development in Lung-disorders in South Korea (IM, Controlled release)
  • 28 Nov 2023 No recent reports of development identified for phase-I development in COVID-2019-infections(In volunteers) in Australia (IM, Controlled release)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top